McCarthy Christopher bought IDXG
February 1, 2024 · Form 4 insider transaction
McCarthy Christopher bought 10,000 shares of Interpace Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderMcCarthy Christopher
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 6, 2024
Shares owned after45,644
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units vested immediately.